Tailin Biotech: Announcement of Resolutions of the 14th Meeting of the 4th Board of Directors
Securities code: 300813 Securities abbreviation: Tailin Biotechnology Announcement number: 2026-046
Zhejiang Tailin Biotechnology Co., Ltd.
Announcement of Resolutions of the Fourteenth Meeting of the Fourth Board of Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Convening of board of directors meetings
The 14th meeting of the fourth board of directors of Zhejiang Tailin Biotechnology Co., Ltd. (hereinafter referred to as the "Company") was held on July 1, 2026 in the company's conference room through on-site combined with communication voting. The notice and meeting materials of this meeting were issued by telephone, written delivery, etc. on June 30, 2026. All directors unanimously agreed to waive the notice time limit for this meeting. Seven directors were supposed to be present at the meeting, but actually seven directors were present. This meeting was convened and chaired by Mr. Ye Dalin, and the company's senior managers attended the meeting.
The convening of this meeting complied with the requirements of the Company Law of the People's Republic of China, the Articles of Association and relevant laws and administrative regulations. The meeting was legal and valid.
2. Review status of board of directors meeting
After deliberation by the directors present at the meeting, the meeting passed the following resolution:
(1) Consideration and approval of the "Proposal on the Company's Plan to Issue Convertible Corporate Bonds to Unspecified Objects (Revised Draft)"
In accordance with the provisions of laws, regulations and normative documents such as the "Company Law of the People's Republic of China", the "Securities Law of the People's Republic of China", the "Measures for the Registration and Administration of Securities Issuance of Listed Companies", and the "Measures for the Administration of Convertible Corporate Bonds", as well as the authorization of the board of directors of the company's 2025 Annual Shareholders Meeting, the company has adjusted the terms such as the use of funds raised in this plan to issue convertible corporate bonds to unspecified objects based on the actual situation. The details are as follows:
- Purpose of funds raised this time
Before adjustment:
The company's issuance of convertible corporate bonds to unspecified objects will raise funds of no more than RMB 230 million (including the original amount), which will be used for the following projects after deducting issuance expenses:
Unit: RMB 10,000 Serial number Project name Total project investment Amount of raised funds to be invested Implementing entity
1 High-performance filter and accessories 32,161.88 20,000.00 Tailin New Materials
Functional film industrialization project
2 Supplementary working capital 3,000.00 3,000.00 Tailin Biotech Total 35,161.88 23,000.00 -
Before the funds raised from the issuance of convertible corporate bonds to unspecified objects are in place, the company will make an early investment with self-raised funds based on the actual needs and priorities of the project. After the funds raised are in place, the relevant funds invested in the early stage will be replaced in accordance with the requirements and procedures of relevant laws and regulations.
The net amount of funds raised from the issuance of convertible corporate bonds to unspecified objects after deducting issuance expenses is less than the total amount of funds to be invested in the above-mentioned projects. The company can make appropriate adjustments to the amount of funds raised in the above-mentioned projects according to the actual needs of the project and in accordance with the procedures stipulated in relevant laws and regulations. The shortfall will be raised by the company itself.
After adjustment:
The company's issuance of convertible corporate bonds to unspecified objects will raise funds of no more than RMB 230 million (including the original amount), which will be used for the following projects after deducting issuance expenses:
Unit: 10,000 yuan Serial number Project name Total project investment Amount of raised funds to be invested Implementation of high-performance filters and supporting facilities
1 32,197.53 20,000.00 Tailin New Material Functional Membrane Industrialization Project
2 Supplementary working capital 3,000.00 3,000.00 Tailin Biotech Total 35,197.53 23,000.00 -
The planned investment portion of the funds raised this time does not include the funds invested before the previous board of directors resolution. Before the funds raised from the issuance of convertible corporate bonds to unspecified objects are in place, the company will make an early investment with self-raised funds based on the actual needs and priorities of the project. After the funds are raised, the company will replace the self-owned funds invested in the project construction related to the project construction after the resolution of the board of directors of this issuance and before the funds are received in accordance with the requirements and procedures of relevant laws and regulations.
The net amount of funds raised from the issuance of convertible bonds to unspecified objects after deducting issuance expenses is less than the total amount of funds to be invested in the above-mentioned projects. The company can make appropriate adjustments to the amount of funds raised in the above-mentioned projects according to the actual needs of the project and in accordance with the procedures stipulated in relevant laws and regulations. The shortfall will be raised by the company itself.
Voting results: 7 votes in favor; 0 votes against; 0 abstentions.
This proposal has been reviewed and approved by the company’s special meeting of independent directors, audit committee, and strategy committee.
(2) Consideration and approval of the "Proposal on the Company's Plan for Issuing Convertible Corporate Bonds to Unspecified Objects (Revised Draft)"
In accordance with the provisions of laws, regulations and normative documents such as the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Measures for the Registration and Administration of Securities Issuance of Listed Companies, the Measures for the Administration of Convertible Corporate Bonds, the company's "Plan for the Issuance of Convertible Corporate Bonds to Unspecified Objects (Revised Draft)" has been prepared. For details, please refer to the "Plan for the Issuance of Convertible Corporate Bonds to Unspecified Objects (Revised Draft)" published by the company on the China Securities Regulatory Commission's designated GEM information disclosure website, Juchao Information Network (http://www.cninfo.com.cn).
This proposal has been reviewed and approved by the company’s special meeting of independent directors, audit committee, and strategy committee. Voting results: 7 votes in favor; 0 votes against; 0 abstentions.
(3) Consider and approve the "Proposal on the Feasibility Analysis Report on the Use of Funds Raised by the Company from Issuing Convertible Corporate Bonds to Unspecified Objects (Revised Draft)"
In accordance with the provisions of laws, regulations and normative documents such as the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Measures for the Registration and Administration of Securities Issuance of Listed Companies, and the Measures for the Administration of Convertible Corporate Bonds, the company's "Feasibility Analysis Report on the Use of Funds Raised by the Issuance of Convertible Corporate Bonds to Unspecified Objects (Revised Draft)" has been prepared.
For details, please refer to the "Feasibility Analysis Report on the Use of Funds Raised by Issuing Convertible Corporate Bonds to Unspecified Objects (Revised Draft)" published by the company on the China Securities Regulatory Commission's designated GEM information disclosure website, Juchao Information Network (http://www.cninfo.com.cn).
This proposal has been reviewed and approved by the company’s special meeting of independent directors, audit committee, and strategy committee. Voting results: 7 votes in favor; 0 votes against; 0 abstentions.
3. Documents for reference
1． Resolution of the 14th meeting of the 4th Board of Directors;
- Resolution of the Fourth Meeting of the Fourth Audit Committee in 2026;
3． Resolution of the second meeting of the Fourth Strategy Committee in 2026;
4． The resolution of the second special meeting of the independent directors of the fourth board of directors in 2026;
- Other documents required by Shenzhen Stock Exchange.
Announcement is hereby made.
Board of Directors of Zhejiang Tailin Biotechnology Co., Ltd.
July 1, 2026